NSE · VALIANTLAB
Valiant Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,739
of 5,004 stocks
🏆 New peak
▲ 291W
Peak #1,739 · 01 Oct 2026
A smallcap name in Healthcare, Valiant Laboratories Limited is growing revenue rapidly, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 75%.
Market Cap
685.59 Cr
P/E Ratio
—
P/B Ratio
2.19
ROE
-1.05%
ROCE
0.78%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 115.29 Cr | 91.98 Cr | 52.46 Cr | 46.20 Cr |
| Net Profit | 21.10 Cr | 1.76 Cr | -7.06 Cr | 20.01 L |
| EPS | 3.89 | 0.32 | -1.30 | 0.04 |
| Operating Profit | 27.26 Cr | 2.06 Cr | -2.31 Cr | 41.24 L |
Shareholding pattern
Promoter
74.94%
Public
25.06%
PUBLIC BREAKDOWN
FII
0.00%
DII
0.00%
MF (within DII)
0.00%
Individuals
19.12%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Jul 2025 | Rights | Rights 1:4 @ Premium Rs 65/- |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.